Published in AIDS Weekly, October 9th, 2006
In a recent report published in the Journal of Acquired Immune Deficiency Syndromes, researchers in the United States conducted a prospective, randomized, double-blinded, placebo-controlled trial to "examine the immunologic, metabolic, and clinical effects of broad spectrum micronutrient supplementation in HIV-infected patients taking highly active antiretroviral therapy (HAART)."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.